Evidence map›Paper›PMID 27115769›Full record

ArticleActa neuropathologica2016

Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci.

Mariet Allen, Jeremy D Burgess, Travis Ballard, Daniel Serie, Xue Wang, Curtis S Younkin, Zhifu Sun, Naomi Kouri, Saurabh Baheti, Chen Wang and 14 more

Abstract read
In one paragraph

Article in Acta neuropathologica, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 3 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 3 syntheses or guidelines pooled it, 91 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Shared genetic architecture between DTI-ALPS traits and neurodegenerative diseases.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  5. Review
  6. Article
  7. Cross-disease genetic and epigenetic architecture of thebioRxiv : the preprint server for biology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 5 institutions in 1 country.

Mariet AllenDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA.
Jeremy D BurgessDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA.
Travis BallardDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA.
Daniel SerieDepartment of Health Sciences Research, Mayo Clinic, Jacksonville, FL, 32224, USA.
Xue WangDepartment of Health Sciences Research, Mayo Clinic, Jacksonville, FL, 32224, USA.
Curtis S YounkinDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA.
Zhifu SunDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, 55905, USA.
Naomi KouriDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA.
Saurabh BahetiDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, 55905, USA.
Chen WangDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, 55905, USA.
Minerva M CarrasquilloDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA.
Thuy NguyenDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA.
Sarah LincolnDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA.
Kimberly MalphrusDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA.
Melissa MurrayDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA.
Todd E GoldeDepartment of Neuroscience, Center for Translational Research in Neurodegenerative Disease, McKnight Brain Institute, University of Florida, Gainesville, FL, 32610, USA.
Nathan D PriceInstitute for Systems Biology, 401 Terry Avenue N, Seattle, WA, 98109, USA.
Steven G YounkinDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA.
Gerard D SchellenbergPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Yan AsmannDepartment of Health Sciences Research, Mayo Clinic, Jacksonville, FL, 32224, USA.
Tamas OrdogDepartment of Physiology and Biomedical Engineering and Center for Individualized Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
Julia CrookDepartment of Health Sciences Research, Mayo Clinic, Jacksonville, FL, 32224, USA.
Dennis DicksonDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA.
Nilüfer Ertekin-TanerDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA. taner.nilufer@mayo.edu.
Mayo Clinic in Florida · USInstitute for Systems Biology · USMayo Clinic · USUniversity of Florida · USUniversity of Pennsylvania · US

Funding

Alzheimer's Disease Genetics ConsortiumU01AG032984 · NIA · UNIVERSITY OF PENNSYLVANIA · PI SCHELLENBERG, GERARD DAVID · 2009 to 2024
$60.4M
Transgenic Mouse Models of Tau PathologiesP01AG017586 · NIA · UNIVERSITY OF PENNSYLVANIA · PI LEE, VIRGINIA M · 2000 to 2021
$37.3M
Integrating the exposome and methylome to inform brain molecular changes in ADRD across established diverse cohorts.U01AG046139 · NIA · UNIVERSITY OF FLORIDA · PI ERTEKIN-TANER, NILUFER, PETERS, METTE · 2013 to 2022
$24.6M
Neuropathology CoreP50NS072187 · NINDS · MAYO CLINIC JACKSONVILLE · PI DICKSON, DENNIS WILLIAM · 2010 to 2017
$8.7M
University of Florida - Mt. Sinai Medical Center AD Research CenterP50AG047266 · NIA · UNIVERSITY OF FLORIDA · PI FEBO, MARCELO · 2015 to 2019
$7.3M
Gene discovery in PSP by transcriptome, neuropathology and sequence analysisR01NS080820 · NINDS · MAYO CLINIC JACKSONVILLE · PI ERTEKIN-TANER, NILUFER · 2013 to 2017
$1.8M
Genome wide association study of gene expression levels in Alzheimer's diseaseR01AG032990 · NIA · MAYO CLINIC JACKSONVILLE · PI ERTEKIN-TANER, NILUFER · 2009 to 2011
$932k
NIA NIH HHS P01 AG017586NIA NIH HHS P50 AG047266NIA NIH HHS R01 AG032990NIA NIH HHS U01 AG032984NIA NIH HHS U01 AG046139NINDS NIH HHS P50 NS072187NINDS NIH HHS R01 NS080820
6 · The paper itself

Abstract

To determine the effects of single nucleotide polymorphisms (SNPs) identified in a genome-wide association study of progressive supranuclear palsy (PSP), we tested their association with brain gene expression, CpG methylation and neuropathology. In 175 autopsied PSP subjects, we performed associations between seven PSP risk variants and temporal cortex levels of 20 genes in-cis, within ±100 kb. Methylation measures were collected using reduced representation bisulfite sequencing in 43 PSP brains. To determine whether SNP/expression associations are due to epigenetic modifications, CpG methylation levels of associated genes were tested against relevant variants. Quantitative neuropathology endophenotypes were tested for SNP associations in 422 PSP subjects. Brain levels of LRRC37A4 and ARL17B were associated with rs8070723; MOBP with rs1768208 and both ARL17A and ARL17B with rs242557. Expression associations for LRRC37A4 and MOBP were available in an additional 100 PSP subjects. Meta-analysis revealed highly significant associations for PSP risk alleles of rs8070723 and rs1768208 with higher LRRC37A4 and MOBP brain levels, respectively. Methylation levels of one CpG in the 3' region of ARL17B associated with rs242557 and rs8070723. Additionally, methylation levels of an intronic ARL17A CpG associated with rs242557 and that of an intronic MOBP CpG with rs1768208. MAPT and MOBP region risk alleles also associated with higher levels of neuropathology. Strongest associations were observed for rs242557/coiled bodies and tufted astrocytes; and for rs1768208/coiled bodies and tau threads. These findings suggest that PSP variants at MAPT and MOBP loci may confer PSP risk via influencing gene expression and tau neuropathology. MOBP, LRRC37A4, ARL17A and ARL17B warrant further assessment as candidate PSP risk genes. Our findings have implications for the mechanism of action of variants at some of the top PSP risk loci.

Indexed as

AllelesDNA MethylationGenome-Wide Association StudyAgedAged, 80 and overFemaleGene ExpressionGenetic LociHumansMaleNeuropathologyPolymorphism, Single NucleotideRiskSupranuclear Palsy, Progressivetau Proteinstau ProteinsAssociationBrain tissueEpigeneticGenetic riskNeuropathology traitsProgressive supranuclear palsyTranscription

Identifiers

PMID27115769
PMCPMC4947429
OpenAlexW2342869776

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.